Vaginal Estrogen Linked to Higher Hip Surgery UTI Risk
Postmenopausal women may face increased perioperative infection risks, making it a key topic for pre-surgery clinical discussions.
Updated on Oct. 22, 2026 in Women’s Health
Live Poll
Do you feel better communication about medication adherence helps patients recover more safely from surgery?
A new study of postmenopausal women suggests that vaginal estrogen use is linked to an increased risk of developing urinary tract infections during the period surrounding a hip fracture. Researchers found that while these users were more likely to have a history of recurrent infections, the association with perioperative UTIs persisted even after adjusting for age.
Why it matters
Understanding this connection is important for women managing hip fracture recovery, as low estrogen levels after menopause contribute to vaginal atrophy that may make the urinary tract more vulnerable to bacterial entry. These findings highlight a specific risk factor that patients should discuss with their clinical team to optimize surgical preparation and post-operative care.
In a study of 375 postmenopausal women aged 50 or older who suffered hip fractures, researchers identified an adjusted odds ratio of 2.56 for perioperative urinary tract infections among vaginal estrogen users. While this demonstrates a significant statistical association, the study is observational and further research is needed to determine the impact of specific medication delivery methods.
The players
Duke University School of Medicine
An academic medical institution that conducted this research regarding postmenopausal health.
The details
Postmenopausal drops in estrogen cause vaginal atrophy, which can impair the body's natural defenses and allow harmful bacteria to migrate into the urethra and bladder. In this study, 32 of the 33 vaginal estrogen users had been using the medication for at least six weeks before their surgery. Researchers noted that low medication adherence may also play a role in the observed health outcomes, though the study did not find significant links between the medication and long-term mortality or hospital readmission.
Timeline
6.3% of women experienced a urinary tract infection within 30 days postoperatively.
8.12% of women experienced a urinary tract infection within 90 days postoperatively.
No significant associations with mortality were found within a year after surgery.
Health Landscape
This research expands upon the ongoing work at the Duke University School of Medicine to understand how common menopausal treatments influence surgical recovery outcomes. It adds to the growing body of evidence examining how hormonal health interventions interact with the physical stress of major orthopedic procedures.
If you are a postmenopausal woman scheduled for orthopedic surgery, it is worth discussing your current medications and history of recurrent urinary tract infections with your surgeon. Your physician can evaluate if your specific hormone therapy regimen requires any adjustments to help minimize your risk of post-operative complications.
The takeaway
While vaginal estrogen is standard for managing postmenopausal symptoms, this study highlights an important consideration for patients undergoing surgery. If you have a history of recurrent urinary tract infections, discuss this risk with your doctor to coordinate your care plan effectively.
Further reading
For more on managing long-term hormonal health and pelvic wellness, see our Women’s Health section.
Live Poll
Do you feel better communication about medication adherence helps patients recover more safely from surgery?
